Acta Haematologica

Papers
(The median citation count of Acta Haematologica is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Treating Leukemia in the Time of COVID-1943
Systematic Review of Microthrombi in COVID-19 Autopsies32
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic26
Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 201926
Accelerated Phase of Myeloproliferative Neoplasms25
A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis21
Hematological Manifestations among Patients with Rheumatic Diseases21
COVID-19 Coagulopathy: From Pathogenesis to Treatment18
The Association between Metabolic Syndrome and Multiple Myeloma17
Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective16
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel15
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?14
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations13
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs13
JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients12
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia an11
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis11
Perspective: SARS-CoV-2, COVID-19 and Haematologists10
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant10
Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia10
Adherence to Immunization: Rebuttal of Vaccine Hesitancy9
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?9
ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report9
Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy9
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy8
<b><i>BCR/ABL1</i></b>-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy8
Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?8
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response8
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma8
Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia7
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids7
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment7
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk7
Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine7
Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience7
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm7
Current and Emerging Treatments for Waldenström Macroglobulinemia7
Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy6
Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma6
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients6
Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity6
A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination6
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments6
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review6
Viscoelastic Coagulation Monitor (VCM<sup>Vet</sup>) Reference Intervals and Sex Differences in Mature Adult Mice6
Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation6
Vaccination for SARS-CoV-2 in Hematological Patients6
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A5
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia5
Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic Thrombocytopenic Purpura5
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Ac5
Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-194
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis4
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry4
Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia4
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune Thrombocytopenia4
Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies4
Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review4
Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review4
Eltrombopag for the Treatment of Severe Inherited Thrombocytopenia4
<b><i>DIAPH1</i></b> Mutation as a Novel Cause of Autosomal Dominant Macrothrombocytopenia and Hearing Loss4
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation4
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?4
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients4
Efficacy of Individualized Preventive Treatment of Patients with Severe Hemophilia A Guided by Multiple Clinical Parameters and Pharmacokinetics4
Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor4
How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?4
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation4
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype4
Effects of Glycosaminoglycan from <b><i>Urechis unicinctus</i></b> on ADP-Induced Platelet Calcium and Membrane Glycoprotein Expressions in Rats3
Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas3
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study3
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature3
Significance of the p.Phe218Ser and p.Gly304Glu F5 Variants in Hereditary Factor V Deficiency3
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia3
PNH Clones for Aplastic Anemia with Immunosuppressive Therapy: A Systematic Review and Meta-Analysis3
Chronic Eosinophilic Leukaemia Associated with <b><i>JAK2</i></b> Exon 13 Insertion/Deletion Mutations3
Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse3
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes3
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response3
Association between Platelet-Associated Immunoglobulin G Levels and Response to Corticosteroid Therapy in Patients with Newly Diagnosed Immune Thrombocytopenia3
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series3
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling3
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer3
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient3
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa3
Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma3
Use of Core-Needle Biopsy for the Diagnosis of Malignant Lymphomas in Clinical Practice3
Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Contr3
STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma3
Survival Disparities in Multiple Myeloma by Health Insurance Status among US Non-Elderly Adults: A SEER-Based Comparative Analysis3
Myeloid Neoplasm with <b><i>PCM1-PDGFRB</i></b> Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review2
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine2
Physician’s Subjective Increase in Awareness towards Perioperative Anaemia, Patient’s Blood Resource, and Transfusion after the Implementation of Patient Blood Management: A Nationwide Multicentre Sur2
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?2
A Gene Signature Comprising Seven Pyroptosis-Related Genes Predicts Prognosis in Pediatric Patients with Acute Myeloid Leukemia2
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices2
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over2
Peculiar Congenital Factor VII Defect with the Proposita and Her Mother Showing the Same Compound Heterozygosity for Thr384Met and Arg413Gln2
Extracellular Vesicles Derived from Human Bone Marrow Stem Cells Inhibit Acute Lymphoblastic Leukemia Cell Growth by Inhibiting MAPK Pathway via the miR-29b-3p/GDF15 Axis2
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient2
Neuropsychiatric Derangement by Polycythemia Vera: A Case Report of an Unexpected Disease Presentation and Review of the Literature2
A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree2
Platelet miR-107 Participates in Clopidogrel Resistance after PCI Treatment by Regulating P2Y122
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia2
Monitoring Minimal Residual Disease in <b><i>RUNX1</i></b>-Mutated Acute Myeloid Leukemia2
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany2
Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile2
Prognostic Markers in the Era of Targeted Therapies2
High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia2
Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report2
The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia2
Prognostic Value of Microvessel Density in Non-Hodgkin Lymphoma: A Meta-Analysis2
Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report2
Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease Evaluation2
Chronic Lymphocytic Leukemia: Disease Biology2
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-2
Role of Inherited Thrombophilia Risk Factors in Patients with CKD-5 Receiving Haemodialysis2
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment2
Timing of Initiation of Calcineurin Inhibitors in Pediatric Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Effects on Survival, Relapse, and Cytokine Release Syndrome2
A Novel ANK1 Mutation in a Neonatal Hereditary Spherocytosis Case: Diagnostic Challenges and Familial Genetic Analysis2
Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma2
Tanshinone IIA Inhibits Tissue Factor Expression Induced by Thrombin in Human Umbilical Vein Endothelial Cells via PAR-1 and p38 MAPK Signaling Pathway2
Imaging of Hematological Patients in the Era of COVID-192
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient2
An Eltrombopag Red (Plasma) Alert2
Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience2
Ageism in the t(11;14) Subtype of Multiple Myeloma2
What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia2
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid Syndrome2
Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness2
Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs1
Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms1
Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future1
Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic Patients1
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort1
Frontline Therapy in Chronic Lymphocytic Leukemia1
Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β<sup>0</sup>-Thalassemia/Hemoglobin E Patients1
Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations1
Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond1
Post-Chemotherapy Histiocyte-Rich Pseudotumors: Radiologic and Endoscopic Mimics of Residual Lymphoma1
Tumor Lysis Syndrome Is Associated with Worse Outcomes in Adult Patients with Acute Lymphoblastic Leukemia1
A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices1
Presence of Parvovirus B19 but Not Herpesvirus Genome in Acute Skin Rash after Allogeneic Stem Cell Transplantation Correlates with Outcome1
Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World Experience1
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective1
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement1
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia1
“The Long Journey of Unexplained Erythrocytosis”: Erythrocytosis due to High-Oxygen Affinity Hemoglobinopathy – Hemoglobin Variant Little Rock (HBB: c.432C&gt;A) – A Report of a Swiss Family and R1
Successful Cord Blood Transplantation for Idiopathic CD4<sup>+</sup> Lymphocytopenia1
Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remiss1
Severe Protein C Deficiency due to Novel Biallelic Variants in <b><i>PROC</i></b> and Their Phenotype Correlation1
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information1
Splenic Micronodular T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis1
Preliminary Study on Apoptotic Proteins in Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura1
T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association1
Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study1
Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease1
Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease1
A Novel Homozygous Frameshift Mutation in ITGB3 Causes Glanzmann’s Thrombasthenia1
Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements1
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Blood Safety1
A Haematologist’s Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop?1
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report1
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review1
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies1
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 20221
The Reality of Pixantrone in Real Life1
Novel JAK2 Exon 14 Mutations L611S or N622Y in cis with JAK2V617F Are Associated with Distinct Clinical Phenotype of Polycythemia Vera and Concurrent Eosinophilia1
A Longitudinal Assessment of the Natural Change in Haemoglobin, Haematocrit, and Mean Corpuscular Volume with Age1
Total Platelet Transcriptomics and Its Network Analysis by RNA-Seq and miRNA-Seq and PCA Application in Essential Thrombocythaemia1
Recapitulated Late-Onset Inflammatory Toxicities and Progressive Dysautonomia with Persistence of Central Memory CD4+ Chimeric Antigen Receptor T Cells in a Case of Transformed Follicular Lymphoma: Ca1
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells1
High Rates of Anti-αIIbβ3 Antibodies Produced by a Glanzmann Thrombasthenia Patient after First and Unique Red Blood Cells Administration1
Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia1
Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study1
Make Family Caregivers Visible, Valued, and Supported: An Interview with Patients’ Caregivers’ Advocate1
Preliminary Investigation about the Expression of G Protein-Coupled Receptors in Platelets from Patients with Chronic Immune Thrombocytopenic Purpura1
Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide1
The Tissue Issue: When to Biopsy Persistent or Refractory Disease in Classic Hodgkin Lymphoma1
A Patient with Kabuki Syndrome Mutation Presenting with Very Severe Aplastic Anemia1
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region1
Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome1
StALKing Histiocytosis: ALK-Positive Histiocytosis Identified through Peripheral Blood Smear1
Anemia in Celiac Disease: Multiple Aspects of the Same Coin1
The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents1
A Systematic Review Assessing the Underrepresentation of Cancer Patients in COVID-19 Trials1
Prophylaxis Using a Mixture of Plasma-Derived Activated Factor VII and Factor X (pdFVIIa/FX) in a Patient with Hemophilia B Complicated by Inhibitors and Allergy to Factor IX Concentrates: A Case Repo1
Glomerulonephritis Secondary to Acute Promyelocytic Leukemia that Resolved after Induction Therapy1
0.027947902679443